Postmenopausal Osteoporosis: Identifying and Managing Patients at High Risk of Fracture

Program Description:

About one-half of all postmenopausal women may have an osteoporosis-related fracture during their lives, posing an enormous health burden with an increasing elderly population. Early detection of bone loss and appropriate management can help to prevent further bone loss, increased bone fragility, and fractures. Primary care physicians have a major role to play in educating patients about osteoporosis, assessing risk, facilitating screening, and administering treatment.

The program was captured live in Denver, CO, on June 4, 2011 and is used with the permission of the presenter.

INTENDED AUDIENCE:

Primary Care Providers

Activity Objectives:

After completing this program participants should be able to:

• Define screening strategies for osteoporosis in postmenopausal women


• Identify candidates for pharmacologic treatment of postmenopausal osteoporosis


• Evaluate and compare available therapies for osteoporosis


• Recognize and overcome barriers to adherence and effectiveness of osteoporosis therapy



Credits	Type	Accreditation Statement	Designation Statement
1.00	AMA PRA Category 1 Credit(s)TM	The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.	The National Association for Continuing Education designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty:

Marjorie M. Luckey, MD
Medical Director, Osteoporosis Center
Saint Barnabas Medical Center
Livingston, NJ

Disclosures:

Marjorie M. Luckey, MD, Speaker, is a consultant for Amgen, Merck, Novartis, Tarsa and Eli Lilly and is a speaker for Amgen, Novartis.

Gregg Sherman, MD, Course Director, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.

Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.

Vernon Hershberger MD, FAAFP, Activity Planning Commitee, serves as a consultant to Amgen and Warner Chilcott; and he conducts contracted research for Pfizer, Ortho-McNeil, Sanofi-aventis, Boehringer Ingelheim, and Sepracor.

Nelson B. Watts, MD, Activity Planning Committee, serves as a speaker for Amgen, Novartis,and Warner Chilcott; a consultant for Amgen, Arena, Baxter, Imagepace, InteKrin, Johnson & Johnson, Lilly, Medpace, Merck, NPS, Orexigen, Pfizer/Wyeth, Takeda, Vivus and Warner Chilcott; and receives research support from Amgen, Merck, and NPS; Co-Founder, Stockholder and Director of OsteoDynamics.

None of the peer reviewers have any relevant financial relationships to disclose.

Privacy Policy
To view the myCME privacy policy, please click here.

To view the privacy policy for the National Association for Continuing Education, please click here.

Commercial Supporter:

Amgen provided commercial support for this enduring activity.

Instructions:

To obtain credit, a score of 60% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.